Place of autograft in the treatment of relapses of aggressive lymphoma: the GELA experience
Bosly, A.; Coiffier, B.
Pathologie-Biologie 41(1): 97
1993
ISSN/ISBN: 0369-8114 PMID: 8316491 Document Number: 420886
Document emailed within 1 workday
Related Documents
Hołowiecki, J.; Giebel, S.; Walewski, J.; Krawczyk-Kuliś, M.łg.; Hellmann, A.; Skotnicki, A.; Dmoszyńska, A.; Romejko, J.; Czyz, J.ła.; Jurczak, W.; Kachel, Łu.; Wojnar, J.; Stella-Hołowiecka, B.; Saduś-Wojciechowska, M.; Sułek, K.; Jedrzejczak, W.ła.; Robak, T.; Mariańska, B.; Szczylik, C.; Warzocha, K. 2003: Autologous hematopoietic stem cell transplantation for the treatment of aggressive non-Hodgkin's lymphoma. the experience of Polish lymphoma research group Polskie Archiwum Medycyny Wewnetrznej 110(2): 863-868Bosly, A.; Coiffier, B. 1997: Recent data on the epidemiology of non-Hodgkin lymphoma. Groupe d'Etudes des Lymphomes de l'Adulte (GELA) Pathologie-Biologie 45(6): 449-452
Kasuya, A.; Hirakawa, S.; Tokura, Y. 2012: Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: transformation from indolent to aggressive phase in association with CCR7-positive conversion Dermatology Online Journal 18(10): 5
Armitage, J.O. 2005: The treatment of patients with aggressive non-Hodgkin's lymphoma Oncology 19(4 Suppl 1: 3-6
Coiffier, B.; Reyes, F. 2005: Best treatment of aggressive non-Hodgkin's lymphoma: a French perspective Oncology 19(4 Suppl 1: 7-15
Sehn, L.H.; Connors, J.M. 2005: Treatment of aggressive non-Hodgkin's lymphoma: a north American perspective Oncology 19(4 Suppl. 1): 26-34
Sotnikov, V.M.; Pan'shin, G.A.; Datsenko, P.V.; Ivashin, A.V.; Smol'tsova, N.N. 2009: The role of adjuvant radiotherapy in the complex treatment of stage III-IV aggressive non-Hodgkin's lymphoma Voprosy Onkologii 55(4): 443-446
Moser, E.C.; Noordijk, E.M.; van Leeuwen, F.E.; Baars, J.W.; Thomas, Jé.; Carde, P.; Meerwaldt, J.H.; van Glabbeke, M.; Kluin-Nelemans, H.C. 2006: Risk of second cancer after treatment of aggressive non-Hodgkin's lymphoma; an EORTC cohort study Haematologica 91(11): 1481-1488
Bondar', N.P.; Kudriavtseva, N.N. 2003: Effect of buspirone on aggressive and anxiety behavior of male mice with various aggressive experience Eksperimental'naia i Klinicheskaia Farmakologiia 66(4): 12-16
Brice, P.; Lepage, E.; Gisselbrecht, C.; Fior, R.; Trédaniel, J.; d'Agay, M.F.; Boiron, M. 1990: Aggressive non Hodgkin lymphoma in the elderly. A retrospective study of 72 patients with clinical features and treatment Nouvelle Revue Francaise D'hematologie 32(2): 153-157
Kreuziger, L.M.B.; Morrison, V.A. 2011: Late relapses in diffuse large B-cell lymphoma Clinical Advances in Hematology and Oncology: H&o 9(9): 709-710
Hal, V.; Fehér, László. 2004: Experience with Risperidone in the treatment of institutionalized mentally retarded patients, with special reference to treatment of aggressive states Neuropsychopharmacologia Hungarica: a Magyar Pszichofarmakologiai Egyesulet Lapja 6(1): 19-25
Merli, F.; Federico, M.; Avanzini, P.; Ilariucci, F.; Stelitano, C.; Iannitto, E.; Colombi, M.; Vallisa, D.; Santagati, G.; Picinini, L. 1998: Weekly administration of vincristine, cyclophosphamide, mitoxantrone and bleomycin (VEMB) in the treatment of elderly aggressive non Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei Linfomi Haematologica 83(3): 217-221
Takaue, Y.; Kawano, Y.; Watanabe, T.; Abe, T.; Hirose, M.; Kuroda, Y.; Ninomiya, T.; Yokobayashi, A.; Matsushita, T.; Uchiyama, H. 1990: Peripheral blood stem cell (PBSC) autograft in the treatment of high-risk leukemia/lymphoma of children. Children's PBSC Autografts Study Group of Japan Bone Marrow Transplantation 5(Suppl 1): 50
Infanti, L.; Silvestri, F.; Fanin, R.; Salmaso, F.; Zaja, F.; Barillari, G.; Patriarca, F.; Geromin, A.; Cerno, M.; Damiani, D.; Baccarani, M. 1996: The F-MACHOP regimen in the treatment of aggressive non-Hodgkin's lymphomas: a single center experience in 72 patients Haematologica 81(6): 521-528
Izumi, T.; Muroi, K.; Hoshino, Y.; Komatsu, N.; Ohtsuki, T.; Yamada, M.; Tomizuka, H.; Hatake, K.; Furusawa, S.; Miura, Y. 1996: Biweekly cyclophosphamide, epirubicin, vincristine and prednisolone (CEOP) chemotherapy for the elderly patients with aggressive non-Hodgkin's lymphoma. Tochigi Malignant Lymphoma Study Group for the Elderly Patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(6): 797-800
Szucs-Farkas, Z.; Peltzer, J.; Berger, D.; Braunschweig, M. 2005: Aggressive lymphoma of the skull in a patient with AIDS Jbr-Btr: Organe de la Societe Royale Belge de Radiologie 88(3): 152-153
Veselý, K. 2010: Lymphoma-like course in aggressive adult multisystem Langerhans cell histiocytosis Vnitrni Lekarstvi 56(11): 1114-1115
Curcio, A.; Bertelli, R.; Gentilini, P.; Ronconi, S.; Saragoni, L.; Vagliasindi, A.; Mura, G.; Mazza, P.; Framarini, M.; Verdecchia, G.M. 2005: Multimodal treatment of gastric MALT lymphoma: our experience I Suppli di Tumori: Official Journal of Societa Italiana di Cancerologia . 4(3): S77-S78
Santini, G.; Coser, P.; Congiu, A.M.; Salvagno, L.; De Souza, C.; Sertoli, M.R.; Olivieri, A.; Chisesi, T.; Rubagotti, A.; Truini, M.; Contu, A.; Porcellini, A.; Zambaldi, G.; Nati, S.; Marino, G.; Rizzoli, V. 2000: VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group Haematologica 85(2): 160-166